Congratulations to the 2025 Community Partnership and Collaboration Core Pilot Grant Recipients
We are pleased to announce the 2025 recipients of the Community and Collaboration Core (CCC) Pilot Grants. The Partnership Development grant provides up to $10,000
Celebrate Excellence at the MLK Commemoration
All are invited to celebrate Dr. Martin Luther King Jr.’s life and legacy of excellence during Johns Hopkins’ 43rd annual MLK Commemoration on Friday, Jan.
Apply for the Translational Science Interagency Fellowship Program
NCATS jointly sponsors the Translational Science Interagency Fellowship (TSIF) with the U.S. Food and Drug Administration to provide training to fellows in translational science and
A Cause of Hyperinflammatory Response in Lethal COVID-19 Identified
As part of the COVID-19 International Research Team, researchers at the Johns Hopkins Kimmel Cancer Center, Children’s Hospital of Philadelphia, the University of Pittsburgh and
Call for Applications: Predoctoral Clinical Research Training Program (PCRTP) T32
Predoctoral Clinical Research Training Program (PCRTP) T32 Application Deadline: Friday, January 10, 2025 Application Information Session Slides | Recording Passcode: *K7=vTpY The Predoctoral Clinical Research Training Program (PCRTP)
Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study
Johns Hopkins Medicine Study Expands Understanding of How Fecal Microbiota Transplants May Work to Restore Gut Health
In a novel study that identified male chromosome genetic material in the intestines of female patients undergoing fecal transplants, researchers at Johns Hopkins Medicine say
Scientists Determine Why Some Patients Don’t Respond Well to Wet Macular Degeneration Treatment, Show How New Experimental Drug Can Bridge Gap
A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or “wet” AMD)
How Hypoxia Helps Cancer Spread
Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they’ve escaped the low-oxygen
Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic
Johns Hopkins Breaks Ground on Building Named in Honor of Henrietta Lacks
University and health system leaders were joined by members of the Lacks family and elected officials Monday to officially kick off an East Baltimore building
Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular
Funding Opportunity! Apply for a Johns Hopkins and Kaiser Permanente Research Collaboration Pilot Award by December 18
The Johns Hopkins and Kaiser Permanente Research Collaboration Committee seeks to fund research projects highlighting the effective synergy of the Johns Hopkins Medicine and Kaiser Permanente collaboration in tackling the complex and intriguing questions vexing both health systems.
ICTR Deputy Directors Christopher Chute, MD, DrPH, and Jeffrey Rothstein, MD, PhD Elected to National Academy of Medicine
Johns Hopkins University faculty members Christopher G. Chute and Jeffrey D. Rothstein are among 100 scholars newly elected to the National Academy of Medicine, announced during the NAM’s annual meeting in
